Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466349019 | Ethinylestradiol+norgestimate 35micrograms/250micrograms tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 466350019 | Ethinyloestradiol+norgestimate 35micrograms/250micrograms tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 718953010 | Ethinylestradiol+norgestimate 35micrograms/250micrograms tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1191051012 | Ethinylestradiol+norgestimate 35micrograms/250micrograms tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3485420018 | Product containing ethinylestradiol 0.035 milligram and norgestimate 0.25 milligram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3485421019 | Ethinyl estradiol 0.035 mg and norgestimate 0.25 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3485422014 | Ethinylestradiol 0.035 mg and norgestimate 0.25 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3485423016 | Product containing ethinyl estradiol 0.035 milligram and norgestimate 0.25 milligram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3485424010 | Product containing ethinylestradiol 0.035 milligram and norgestimate 0.25 milligram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566991011 | Product containing only ethinyl estradiol 0.035 milligram and norgestimate 0.25 milligram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566992016 | Product containing only ethinylestradiol 0.035 milligram and norgestimate 0.25 milligram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3566993014 | Product containing only ethinylestradiol 0.035 milligram and norgestimate 0.25 milligram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699794017 | Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699795016 | Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699796015 | Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699797012 | Ethinyl estradiol 35 microgram and norgestimate 250 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Ethinylestradiol 35mcg+progestogen | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hormone | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Progesterone | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Estradiol | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Synthetic progestogen (substance) | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing ethinylestradiol and norgestimate (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Norgestimate | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Norgestimate | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Norgestimate | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 250 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ethinylestradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 35 | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.25 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.035 | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinylestradiol | false | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Norgestimate | false | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Contraceptive therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Norgestimate | true | Inferred relationship | Some | 2 | |
| Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Norgestimate | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR